Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Use of Telecardiology
4.2.2 Ease of Use and Portability of Cardiac Arrhythmia Monitoring Devices
4.2.3 Development of Smart Cardiac Monitors
4.3 Market Restraints
4.3.1 Poor Adoption of Telemetry Technology in Emerging Markets
4.3.2 High Cost of Remote Cardiac Arrhythmia Monitoring
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Devices
5.1.1 Event Monitoring Devices
5.1.2 Continuous Rhythm Monitoring Devices
5.1.3 Holter Monitoring Devices
5.1.4 Other Devices
5.2 By Service Providers
5.2.1 Mobile Cardiac Telemetry Monitoring Service Providers
5.2.2 Independent Diagnostic Testing Facilities/Clinics
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 ACSDiagnostics
6.1.2 AliveCor Inc.
6.1.3 Abbott Laboratories
6.1.4 Biotronik
6.1.5 GE Healthcare
6.1.6 iRhythm Technologies Inc.
6.1.7 Medi-Lynx
6.1.8 Medtronic PLC
6.1.9 Koninklijke Philips NV
6.1.10 Welch Allyn
6.1.11 Spacelabs Healthcare Inc.
6.1.12 Fukuda Denshi


7 MARKET OPPORTUNITIES AND FUTURE TRENDS